| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/02/2002 | US6365379 Zinc finger peptide cleavage of nucleic acids |
| 04/02/2002 | US6365378 Amplifying a dna fragment, drying product to make powder, supplying powder into solution supply apparatus, adding buffer solution to prepare sample solution; then sample solution is applied directly to chip; reduces loss |
| 04/02/2002 | US6365377 Recombination of insertion modified nucleic acids |
| 04/02/2002 | US6365375 Method of primer-extension preamplification PCR |
| 04/02/2002 | US6365374 2′-deoxy-2′-alkylnucleotide containing nucleic acid |
| 04/02/2002 | US6365373 Which have tyrosine kinase receptor c (trkc)-binding activity and trkc-signal inducing activity; nucleic acids, expression vectors, host cells; treating diabetic peripheral neuropathy |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365365 Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
| 04/02/2002 | US6365361 Method for identifying or screening agonist and antagonist to PPAR |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365358 Polypeptide of defined amino acid sequence; diagnosis, prevention and treatment of cancer, developmental, autoimmune and nervous system disorders; anticarcinogenic agents; antiinflammatory agents |
| 04/02/2002 | US6365357 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein |
| 04/02/2002 | US6365354 Antisense modulation of lysophospholipase I expression |
| 04/02/2002 | US6365351 Non-invasive method for detecting target RNA |
| 04/02/2002 | US6365350 Method of DNA sequencing |
| 04/02/2002 | US6365348 Obtaining biological sample, generating cdna, contacting with oligonucleotide primers of defined nucleotide sequence in polymerase chain reaction, detecting amount of cdna sequence that amplifies; using predetermined cut-off value |
| 04/02/2002 | US6365347 Transforming host cells with recombinant vectors that encode a carrier protein and a random peptide sequence; protein is expressed intracelllularly; detecting interaction between random peptide and target molecule |
| 04/02/2002 | US6365346 Quantitative determination of nucleic acid amplification products |
| 04/02/2002 | US6365345 Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a role |
| 04/02/2002 | US6365344 Screening library of randomized nucleic acids using retroviral vectors to transfect mammalian cells, expressing as extracellular bioactive peptides, contacting other mammalian cells, and screening for changed physiology |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365157 Angiogenesis inhibitors; antitumor agents |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | US6365150 Mixture of vectors; genetic engineering; transfection |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | CA2359465A1 The application of bi-directional promoters for modification of gene expression |
| 04/02/2002 | CA2252664C Method and apparatus for data transmission using multiple transmit antennas |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2182483C Il-3 variant hematopoiesis fusion protein |
| 04/02/2002 | CA2147875C Crf binding protein |
| 04/02/2002 | CA2124214C Materials and methods for biosynthesis of serine and serine-related products |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/28/2002 | WO2002025285A1 Prognostic indicator |
| 03/28/2002 | WO2002025270A1 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 03/28/2002 | WO2002024956A2 Genetic markers for tumors |
| 03/28/2002 | WO2002024954A1 Modified selex processes without purified protein |
| 03/28/2002 | WO2002024953A1 Method for generating recombinant polynucleotides |
| 03/28/2002 | WO2002024950A2 Methods and means of rna analysis |
| 03/28/2002 | WO2002024947A2 Cancer associated protein kinases and their uses |
| 03/28/2002 | WO2002024946A2 Quadruplex dna and duplex probe systems |
| 03/28/2002 | WO2002024940A2 Means for the identification of compounds capable of inhibiting karap-transduced signals |
| 03/28/2002 | WO2002024936A1 Process for the fermentative preparation of d-pantothenic acid using coryneform bacteria |
| 03/28/2002 | WO2002024934A1 Chimeric vectors and their use for heterologous genes transfer |
| 03/28/2002 | WO2002024933A2 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 03/28/2002 | WO2002024932A2 Expression vectors containing hybrid ubiquitin promoters |
| 03/28/2002 | WO2002024931A1 Expression system for functional nucleic acids |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024928A1 Corynebacterium glutamicum nucleotide sequence coding for the pepc gene |
| 03/28/2002 | WO2002024927A2 Regulation of human adam-ts 1 precursor-like protein |
| 03/28/2002 | WO2002024926A1 Talaromyces xylanases |
| 03/28/2002 | WO2002024925A2 69109, a novel human tyrosine phosphatase and uses therefor |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024922A1 Nucleotide sequences which code for the def gene |
| 03/28/2002 | WO2002024921A2 3700, a novel human protein kinase and uses therefor |
| 03/28/2002 | WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | WO2002024919A1 Nucleotide sequences coding for the thya gene |
| 03/28/2002 | WO2002024918A1 Promoter sequences |
| 03/28/2002 | WO2002024917A2 Method for modifying the genome of corynebacteria |
| 03/28/2002 | WO2002024916A1 Complex |
| 03/28/2002 | WO2002024915A1 Dcta (c4-dicarboxylate transporter) from corynebacterium glutamicum |
| 03/28/2002 | WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation |
| 03/28/2002 | WO2002024913A2 32612, a novel human peptide transporter and uses therefor |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024911A2 63760, a novel human transporter and uses thereof |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024908A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 03/28/2002 | WO2002024907A2 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | WO2002024906A1 Induction of exon skipping in eukaryotic cells |
| 03/28/2002 | WO2002024905A1 Method of judging gene mutation |
| 03/28/2002 | WO2002024904A2 Method for producing ribonucleic acid (rna) |
| 03/28/2002 | WO2002024902A1 Method of synthesizing polynucleotide |
| 03/28/2002 | WO2002024901A1 Method of forming complex |
| 03/28/2002 | WO2002024899A2 Improved system for regulation of transgene expression |
| 03/28/2002 | WO2002024897A2 Conditionally replicating viral vectors and their use |
| 03/28/2002 | WO2002024896A2 Screening assays for agonists or antagonists of receptor activat or of nf-kb |
| 03/28/2002 | WO2002024893A2 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF |
| 03/28/2002 | WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024890A2 Rice mlh1 ortholog and uses thereof |
| 03/28/2002 | WO2002024888A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024886A2 Regulation of human serine protease |
| 03/28/2002 | WO2002024885A2 Regulation of human g protein-coupled receptor |
| 03/28/2002 | WO2002024884A2 Regulation of human serine palmitoyltransferase-like enzyme |
| 03/28/2002 | WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/28/2002 | WO2002024880A1 Nucleotide sequences which code for the ndka gene |
| 03/28/2002 | WO2002024879A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 03/28/2002 | WO2002024872A2 Manipulation of spermatozoa |
| 03/28/2002 | WO2002024868A2 Non-human model of gestational and adult folate deficiency and uses thereof |
| 03/28/2002 | WO2002024864A2 Antisense modulation of syntaxin 4 interacting protein expression |
| 03/28/2002 | WO2002024815A1 Cyanine dyes |
| 03/28/2002 | WO2002024755A1 Polystyrene microspheres and a method for their production |